Lululemon is a bitter pill to swallow for those who watched the share price drop sharply based on guidance. Now trading at the lowest multiples we’ve seen in the past decade, is this a speculative buy for those brave enough to wade into tariff uncertainty?

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here